Chimerix and ContraVir Pharma establish strategic collaboration for antiviral drug
Chimerix and ContraVir Pharmaceuticals announced a strategic collaboration for the further clinical development and commercialization of CMX157. CMX157 is a highly potent analog of the successful antiviral drug tenofovir DF (Viread®). December 18, 2014